Parkinsonism & Related Disorders
Volume 16, Issue 7 , Pages 434-437 , August 2010

The cause of death in idiopathic Parkinson’s disease

  • Susan Pennington

      Affiliations

    • ST3 Palliative Medicine Marie Curie hospice, Marie Curie Drive, Newcastle upon Tyne, NE4 6SS, UK
    • ,
  • Kalyani Snell

      Affiliations

    • SpR Palliative Medicine, Marie Curie hospice, Marie Curie Drive, Newcastle upon Tyne, NE4 6SS, UK
    • ,
  • Mark Lee

      Affiliations

    • Consultant in Palliative Medicine, St Benedict’s Hospice, Monkwearmouth Hospital, Newcastle Road, Sunderland, SR5 1NB, UK
    • ,
  • Richard Walker

      Affiliations

    • Consultant Physician and Honorary Professor, Department of Medicine, North Tyneside General Hospital, Rake Lane, North Shields, Tyne and Wear, NE28 9NH, UK
    • Corresponding Author InformationCorresponding author. Tel./fax: +44 191 293 2709.

Received 19 January 2010 ,Revised 23 April 2010 ,Accepted 25 April 2010.

References 

  1. Diem-Zangerl A, Seppi K, Wenning GK, Trinka E, Ransmayr G, Oberaigner W, et al. Mortality in Parkinson’s disease: a 20-year follow-up study. Mov Disord. 2009;24:819–825
  2. D’Amelio M, Ragonese P, Morgante L, Reggio A, Callari G, Salemi G, et al. Long-term survival of Parkinson’s disease: a population-based study. J Neurol. 2006;253:33–37
  3. Fall PA, Saleh A, Fredrickson M, Olsson JE, Granerus AK. Survival time, mortality, and cause of death in elderly patients with Parkinson’s disease: a 9-year follow-up. Mov Disord. 2003;18:1312–1316
  4. Nath U, Thomson R, Wood R, Ben-Shlomo Y, Lees A, Rooney C, et al. Population based mortality and quality of death certification in progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome). J Neurol Neurosurg Psychiatr. 2005;76:498–502
  5. Bennett DA, Beckett LA, Murray AM, Shannon KM, Goetz CG, Pilgrim DM, et al. Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med. 1996;334:71–76
  6. Snell K, Pennington S, Lee M, Walker R. The place of death in Parkinson’s disease. Age Ageing. 2009;38:617–619
  7. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease – a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatr. 1992;55:181–184
  8. World Health Organization . International classification of diseases. Geneva: WHO; 1977;Ninth Revision
  9. World Health Organization . International statistical classification of diseases and related health problems. Geneva: WHO; 1992;Tenth Revision
  10. Rooney C, Smith S. Implementation of ICD-10 for morality data in England and Wales from January 2001. Health Stat Q. 2000;8:41–50
  11. Porter B, MacFarlane R, Unwin N, Walker R. The prevalence of Parkinson’s disease in an area of North Tyneside in the North-East of England. Neuroepidemiology. 2006;26:156–161
  12. NHS end of life care . Advance care planning: a guide for health & social care staff. Nottingham: University of Nottingham; 2008;
  13. Woodford H, Walker R. Emergency hospital admissions in idiopathic Parkinson’s disease. Mov Disord. 2005;20:1104–1108
  14. Beyer MK, Herlofson K, Aarsland D, Larsen JP. Causes of death in a community-based study of Parkinson’s disease. Acta Neurol Scand. 2001;103:7–11
  15. Ebmeier KP, Calder SA, Crawford JR, Stewart L, Besson JA, Mutch WJ. Mortality and causes of death in idiopathic Parkinson’s disease: results from the Aberdeen whole population study. Scott Med J. 1990;35:173–175
  16. Ben-Shlomo Y, Marmot MG. Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology?. J Neurol Neurosurg Psychiatr. 1995;58(3):293–299
  17. Louis ED, Marder K, Cote L, Tang M, Mayeux R. Mortality from Parkinson disease. Arch Neurol. 1997;54:260–264
  18. Hughes TA, Ross HF, Mindham RHS, Spokes EGS. Mortality in Parkinson’s disease and its association with dementia and depression. Acta Neurol Scand. 2004;110:118–123
  19. Hely MA, Morris JGL, Traficante R, Reid WGJ, O’Sullivan DJ, Williamson PM. The Sydney multicentre study of Parkinson’s disease: progression and mortality at 10 years. J Neurol Neurosurg Psychiatr. 1999;67:300–307
  20. Diamond SG, Markham CH, Hoehn MM, McDowell FH, Muenter MD. Effect of age at onset on progression and mortality in Parkinsons-disease. Neurology. 1989;39:1187–1190
  21. Goetz C, Stebbins G. Mortality and hallucinations in nursing home patients with advanced Parkinson’s disease. Neurology. 1995;45:669–671
  22. Roos RAC, Jongen JCF, van der Velde EA. Clinical course of patients with idiopathic Parkinson’s disease. Mov Disord. 1996;11:236–242
  23. Morens DM, Davis JW, Grandinetti A, Ross GW, Popper JS, White LR. Epidemiologic observations on Parkinson’s disease: incidence and mortality in a prospective study of middle-aged men. Neurology. 1996;46:1044–1050
  24. Office for National Statistics. English Life Tables No. 16 (2000-2002), 2002 [Cited on 2010 13th April]; Available at: http://www.statistics.gov.uk/StatBase/Product.asp?vlnk=333
  25. Suchowersky O, Reich S, Perlmutter J, Zesiewicz T, Gronseth G, Weiner WJ. Practice parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review) report of the quality standards subcommittee of the American academy of neurology. Neurology. 2006;66:968–975
  26. Marttila RJ, Rinne UK. Progression and survival in Parkinson’s disease. Acta Neurol Scand Suppl. 1991;136:24–28

☆ The review of this paper was entirely handled by the Co-Editor-in-Chief, Ronald Pfeiffer.

PII: S1353-8020(10)00099-4

doi: 10.1016/j.parkreldis.2010.04.010

Parkinsonism & Related Disorders
Volume 16, Issue 7 , Pages 434-437 , August 2010

Article Tools